Assessing the impact of comorbidities on disease severity in COVID-19 patients requires consideration of age.

Publication date: Jan 31, 2025

Older age and comorbidities are risk factors for increased coronavirus disease 2019 (COVID-19) severity, but few studies have explored their interaction. This study aimed to assess the actual impacts of these factors on disease severity in COVID-19. The enrolled COVID-19 patients were divided into 4 age subgroups (≤44, 45-59, 60-74, and ≥75 years). Logistic regression analysis was conducted to determine the association between comorbidities and disease severity; Kappa consistency test was implemented to verify the study results. Of the 1663 patients with COVID-19, 287 had severe disease. The disease severity was correlated with the age-adjusted Charlson Comorbidity Index in each age group. In the 4 subgroups, the odds ratio of age-adjusted Charlson Comorbidity Index declined with age. After removing age interference, diabetes and cardio-cerebrovascular diseases were the main risk factors for severe disease in patients aged

Concepts Keywords
Cardio Adult
Coronavirus Age Factors
Covid Aged
Diabetes Aged, 80 and over
Older China
Comorbidity
COVID-19
Female
Humans
Male
Middle Aged
Retrospective Studies
Risk Factors
SARS-CoV-2

Semantics

Type Source Name
disease MESH COVID-19
disease MESH Comorbidity
disease MESH cerebrovascular diseases
disease MESH Long Covid

Original Article

(Visited 2 times, 1 visits today)